Giffin Marian, McLeish Sally
Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA.
Biotechnol Annu Rev. 2003;9:279-84. doi: 10.1016/s1387-2656(03)09007-0.
As the pharmaceutical and biotechnology industry enters the 21st century, the pressure on companies to maintain the level of productivity required for consistent year-on-year growth is increasing. Benchmarking has become a tool for obtaining the information needed to support continuous improvement and gain a competitive advantage. During the process of benchmarking, best practices can be identified while giving management the ability to improve on existing performance in an objective, well-informed manner. When used appropriately, benchmarking provides a new perspective on traditional methods while enabling companies to monitor their performance.
随着制药和生物技术行业步入21世纪，各公司要保持逐年持续增长所需的生产力水平面临着越来越大的压力。标杆管理已成为获取支持持续改进和获得竞争优势所需信息的一种工具。在标杆管理过程中，可以识别出最佳实践，同时使管理层能够以客观、明智的方式改进现有绩效。如果使用得当，标杆管理能为传统方法提供新视角，同时让公司能够监控自身绩效。
